glp 1 agonist perioperative 🔸 Should GLP-1 RAs be continued preprocedurally? 🔸 Who should stop a GLP-1 RA preoperatively? 🔸 Which patients should have their procedures postponed? “Perioperative Management of Patients Taking GLP-1 Receptor Agonists” explores Glucagon-Like Peptide-1 Receptor Agonists in

Drugs, route of administration, indication, distribution channel, end-user, and geography segment the Latin America glucagon-like peptide-1 (GLP-1) agonists market

Christel, C

the specific profile depends on the compound and trial design

Secondary endpoints included the rate of patients with a weight loss of 10%, monthly headache days (MHD), the rate of patients with a 30% and 50% reduction in MHD, visual outcome parameters, and adverse events (AEs)

is growing due to the high prevalence of obesity and strong clinical acceptance of GLP-1 therapies for long-term weight management

To optimize model performance, we used tenfold cross-validation to select the optimal hyperparameter ( k ) from a range of values ( k = 5, 10, 15, 20)